Merck Doubles Down on Biologics, Closing Plants and Cutting Jobs

Merck & Co. filed with the U.S. Securities and Exchange Commission that it plans an extensive restructuring of its manufacturing and supply network. This will, it indicates, reduce its “global real estate footprint.”